eISSN: 2572-8474
Submit manuscript...
Opinion Volume 11 Issue 2
Anticancer drug, development perspectives
Da Yong Lu
Received: April 12, 2025 | Published: June 19, 2025
Citation: Lu DY. Anticancer drug, development perspectives. Nurse Care Open Acces J. 2025;11(2):47-49. DOI: 10.15406/ncoaj.2025.11.00319
Abstract
Anticancer drug development is facing ever-increasing challenge. A huge number of chemicals or bio-agents should be evaluated pharmacologically and clinically. Due to lack of funds and human resources, high-quality and robust drug evaluation needs jointefforts between chemists and pharmacologists. New generation of drug evaluation and development is undertaken and renewed with high-throughput biotechnology and genomic/ molecular mechanistic exploration. This Article provides this area of anticancer drug design, evaluation, discovery and licensing with balanced and careful efforts.
Keywords: Anticancer drug development, neoplasm metastasis, pharmaceutical technology, cancer stem cells
©2025 Lu. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.